ALK inhibitors: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
*[[ALK positive lung cancer]]. | *[[ALK positive lung cancer]]. | ||
*[[ALK translocation renal cell carcinoma]]. | *[[ALK translocation renal cell carcinoma]]. | ||
*[[ROS1-rearranged non-small cell lung carcinoma]]. | |||
==References== | ==References== | ||